Key result
C-type natriuretic peptide induced a significant dose-dependent increase in human spermatozoa motility (P=0.001 at 10^-6 mol/L) and acrosome reaction (P<0.0001 at 10^-6 mol/L) compared to control.
Why the study?
Does C-type natriuretic peptide improve sperm motility and acrosome reaction in normal human spermatozoa in vitro?
Does C-type natriuretic peptide improve sperm motility and acrosome reaction in normal human spermatozoa in vitro?
p-value: p=<0.0001
C-type natriuretic peptide and its receptor NPR-B are present in human sperm and can dose-dependently enhance sperm motility and acrosome reaction in vitro.
May enhance sperm function in vitro; leaves open therapeutic role in male infertility pending clinical trials.
C-type natriuretic peptide (CNP) is a newly discovered type of local regulatory factor that mediates its biological effects through the specific, membrane-bound natriuretic peptide receptor-B (NPR-B). Recent studies have established that CNP is closely related to male reproductive function. The aims of this study were to determine the distribution of CNP/NPR-B in human ejaculated spermatozoa through different methods (such as immunolocalization, real time polymerase chain reaction and Western Blot), and then to evaluate the influence of CNP on sperm function i n vitro, such as motility and acrosome reaction. Human semen samples were collected from consenting donors who met the criteria of the World Health Organization for normozoospermia. Our results show that the specific receptor NPR-B of CNP is localized in the acrosomal region of the head and the membrane of the front-end tail of the sperm, and there is no signal of CNP in human sperm. Compared with the control, CNP can induce a significant dose-dependent increase in spermatozoa motility and acrosome reaction. In summary, CNP/NPR-B can affect sperm motility and acrosome reaction, thus regulating the reproductive function of males. CNP may be a new key factor in regulating sperm function.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2015) studied Normozoospermia (n=15). C-type natriuretic peptide (CNP) vs. Ham's F-10 medium alone (control) was evaluated on Sperm motility and acrosome reaction (p=<0.0001). C-type natriuretic peptide induced a significant dose-dependent increase in human spermatozoa motility (P=0.001 at 10^-6 mol/L) and acrosome reaction (P<0.0001 at 10^-6 mol/L) compared to control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: